4.7 Article

IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells

Journal

LEUKEMIA
Volume 25, Issue 5, Pages 828-837

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/leu.2011.12

Keywords

chronic lymphocytic leukemia; immunoglobulin mutational status; tumor microenvironment

Funding

  1. Regione Piemonte (Ricerca Sanitaria, Ricerca Scientifica e Progetto Strategico ImmOnc)
  2. MIUR (Roma, Italy)
  3. Compagnia San Paolo di Torino (Torino, Italy)
  4. Fondazione Neoplasie Sangue Onlus (Torino, Italy)
  5. Associazione per lo Studio e la Cura delle Malattie del Sangue (Torino, Italy)
  6. Italian Association for Cancer Research (AIRC)
  7. Fondazione CRT

Ask authors/readers for more resources

Tumor cells in chronic lymphocytic leukemia (CLL) are more prone to apoptosis when cultured ex vivo, because they lack prosurvival signals furnished in vivo via B-cell receptor (BCR)-dependent and -independent pathways. This study compared the susceptibility of unmutated (UM) and mutated (M) CLL B cells to spontaneous apoptosis and prosurvival signals. UM CLL B cells showed a significantly higher rate of spontaneous apoptosis than M CLL B cells. Nuclear factor-kB (NF-kB) was rapidly inactivated, and B-cell leukemia/lymphoma 2 (Bcl-2) expression progressively down-regulated in the UM CLL B cells. CD40-Ligand, interleukin-4 and stromal cells significantly improved their viability and partially recovered Bcl-2, but not NF-kB expression. Peripheral blood mononuclear cells also offered protection of UM CLL B cells, and recovered both NF-kB and Bcl-2 expression. T cells, rather than nurse-like cells, were responsible for protecting UM CLL B cells by means of cell-to-cell contact and soluble factors. Despite their more aggressive features, UM CLL B cells are more susceptible to spontaneous apoptosis and depend from environmental prosurvival signals. This vulnerability of UM CLL B cells can be exploited as a selective target of therapeutic interventions. Leukemia (2011) 25, 828-837; doi: 10.1038/leu. 2011.12; published online 4 March 2011

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available